Apollon logo

Apollon

The wearable that reads your glucose

40 employees · est. 2021 · Seoul, Korea South

VS
GlucoSet logo

GlucoSet

Intensive care monitoring

16 employees · est. 2011 · Norway

GlucoSet is the older company (2021 vs 2011).

Side-by-Side Comparison

Apollon GlucoSet
Founded
2021 2011 older
Headquarters
Seoul, Korea South Norway
Employees
40 16
Industry
Biotechnology, Health Care, Medical Devices Biotechnology, Health Care, Medical Devices
Funding Stage
Seed Unknown
Total Funding
$2.30B $8.50M
Funding Rounds
2 5
Services
Development of needle-free continuous glucose monitors, Research and innovation in Raman-based glucose sensing, Integration of optical engineering in wearable medical devices Continuous blood glucose monitoring devices, Minimally invasive sensor solutions, ICU cost reduction strategies, Glucose normalization technology
Target Customers
Individuals with diabetes, Healthcare professionals, Medical institutions, Patients seeking non-invasive monitoring solutions Hospitals, Intensive Care Units, Healthcare Providers, Medical Professionals, Healthcare Systems
Taxonomy
Wearable Technology, Glucose Monitoring, Diabetes Management, Non-invasive Medical Devices, Raman Spectroscopy, Medical Technology Innovation, Biomedical Engineering, Clinical Trials, MIT Collaboration, Harvard-affiliated Research, Medical Device Startup, Continuous Monitoring Technology Intensive Care Unit, Glucose Monitoring, Intravascular Sensors, Continuous Monitoring, Blood Glucose Control, Patient Outcomes, Healthcare Cost Reduction, Patient Safety, Infection Prevention, Sensor Technology, Clinical Application, Critical Care Solutions
Website
apollon.bio glucoset.com
Apollon logo

About Apollon

Apollon, founded in 2021, is revolutionizing diabetes management with Moglu, a pioneering wearable that continuously reads glucose through the skin without needles, patches, or consumables. This innovative device leverages Raman spectroscopy, developed alongside MIT, and is currently undergoing clin...

GlucoSet logo

About GlucoSet

GlucoSet, founded in 2011 and headquartered in Norway, is poised to revolutionize the Intensive Care Unit (ICU) environment with its cutting-edge biotechnology solutions. The company operates in the Biotechnology, Health Care, and Medical Devices industries, focusing on addressing critical health ch...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Apollon and GlucoSet — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Apollon and GlucoSet — by email.

Frequently Asked Questions

Apollon — The wearable that reads your glucose. GlucoSet — Intensive care monitoring. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Apollon has raised $2.30B while GlucoSet has raised $8.50M.
Apollon and GlucoSet operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Apollon with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy